A 42-year-old male presented with right-sided weakness, dysphasia and seizures while climbing the French Alps at an approximate altitude of 3,000 m. Imaging studies were consistent with superior sagittal sinus thrombosis with hemorrhage. Laboratory testing for thrombophilic states, 18 days after presentation at our hospital, showed a low protein C level (0.32 U/ml, normal 0.80–1.60 U/ml). A family member was also found to have protein C deficiency without a history of thrombosis. The patient gradually improved and was discharged on warfarin and valproic acid. This is the first reported case of cerebral venous thrombosis in a patient with congenital protein C deficiency who ascended to high altitude. We postulate that the ascent to high altitude represented an additional prothrombotic risk factor to the congenital protein C deficiency leading to cerebral thrombosis.

Broekmans AW, Veltkamp JJ, Bertina RM: Congenital protein C deficiency and venous thromboembolism: A study of three Dutch families. N Engl J Med 1983;309:430–434.
Vieregge P, Schwieder G, Kompf D: Cerebral venous thrombosis in hereditary protein C deficiency. J Neurol Neurosurg Psychiatry 1989;52:135–137.
Clouse LH, Comp PC: The regulation of hemostasis: The protein C system. N Engl J Med 1986;314:1298–1304.
Seligsohn U, Berger A, Abend MD, Rubin L, Attias D, Zivelin A, Rapaport SI: Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984;310:559–562.
Miletich J, Sherman L, Broze G: Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987;317:991–996.
Nguyen P, Reynaud J, Pouzol P, Munzer M, Richard O, Francois P: Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children. Eur J Pediatr 1994;153:646–649.
Dickson J, Heath D, Gosney J, Williams D: Altitude-related deaths in seven trekkers in the Himalayas. Thorax 1983;38:646–656.
Song S-Y, Asaji T, Tanizaki Y, Fujimaki T, Matsutani M, Okeda R: Cerebral thrombosis at altitude: Its pathogenesis and the problems of prevention and treatment. Aviat Space Environ Med 1986;57:71A–76A.
Andrew M, O’Brodovich H, Sutton J: Operation Everest II: Coagulation system during prolonged decompression to 282 Torr. J Appl Physiol 1982;53:40–43.
Simon-Schnass I, Korniszewski L: The influence of vitamin E on rheological parameters in high altitude mountaineers. Int J Vitam Nutr Res 1990;60:26–34.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.